JUST IN – #Pfizer forecasts $54 billion coronavirus-related sales in 2022 from its Covid vaccine and anti-viral pill.
— Disclose.tv (@disclosetv) February 8, 2022
Pfizer forecasts 2022 sales and profit that fall short of Wall Street estimates after expectations for its Covid-19 vaccine and recently cleared oral therapy disappointed investors https://t.co/J1JGyYy24D
— Bloomberg (@business) February 8, 2022